Green Biologics wins BDC Commercialization Achievement Award
In Virginia, the Biorenewable Deployment Consortium gave Green Biologics the organization’s Spring 2017 Commercialization Achievement Award at its spring meeting in Des Moines on May 2, 2017. Green Biologics is recognized for its leadership in the biorenewable industry and successful commercialization of renewable alternatives to n-butanol, acetone and its associated derivatives. These chemicals serve as vital components to downstream products across various industries, including CASE (coatings, adhesives, sealants and elastomers), HI&I (household, industrial & institutional cleaners), PCI (personal care intermediates), food ingredients and energy chemicals.
Green Biologics officially began customer shipments at its first commercial facility in Little Falls, MN, in December 2016, marking the culmination of a years’-long effort to create a robust, global network of customers and partners. These relationships have enabled the company to bring its 100 percent bio-based products to numerous downstream markets and specialty applications. As a result, Green Biologics has further strengthened its position as a global renewable specialty chemicals company, and reinforced its ability to meet the needs of today’s producers and consumers, who are demanding environmentally-conscious alternatives to longstanding products.
“The Biorenewable Deployment Consortium is proud to honor Green Biologics with its Spring 2017 Commercialization Achievement Award,” said BDC Chairman and Co-Founder Ben Thorp. “Green Biologics is a great example of a company that is effectively using its technology platform to produce a wide range of sustainable feedstocks into high performance green chemicals and industrial products. Its commercial plant in Little Falls, MN is the reason that BDC has recognized Green Biologics and awarded its global team for its continued success.”
Category: Fuels
